JUDITH HATCH: Open Payments
NPI 1770899387 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 13 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Genentech USA, Inc. | 1 | $31 |
| Incyte Corporation | 1 | $30 |
| Alexion Pharmaceuticals, Inc. | 1 | $30 |
| PFIZER INC. | 1 | $27 |
| GENZYME CORPORATION | 1 | $27 |
| Aveo Pharmaceuticals, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
Products named: Venclexta, CARVYKTI, JAKAFI, ULTOMIRIS, IBRANCE, AYVAKIT, FRUZAQLA, FOTIVDA.
Industry payments across KY — which companies pay providers there.
